Navigation Links
Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
Date:12/11/2012

redict", "intend" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law.

Note: Data in this release correspond to ASH Abstract 904.


'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
6. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
7. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
8. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
9. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
10. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 28, 2014 China Nepstar Chain Drugstore ... "Company"), a leading retail drugstore chain in China ... today announced its unaudited financial results for the ... HighlightsFor the quarter ended June 30, 2014: , ... compared to RMB638.8 million in the second quarter ...
(Date:8/27/2014)... TWi Pharmaceuticals, Inc. (4180.TT) today announced that ... States Food and Drug Administration (FDA) on its ... 125mg/ml oral suspension, the generic equivalent to Par ... under Hatch Waxman rules, it will be entitled ... completed the pre-launch preparation of the generic drug.  ...
(Date:8/27/2014)... 27, 2014 Reportbuyer.com has added ... Collaborative R&D Terms & Agreements in Pharma, ... The Collaborative R&D Terms and ... provides comprehensive understanding and unprecedented access to ... into by the worlds leading life science ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 4Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 5Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 6Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 7Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 9
... Evergreen Hospital today announced that revolutionary three-dimensional ... available for patient appointments at the Evergreen Breast ... in the Seattle area to offer the breakthrough ... uses precise, three-dimensional (3-D) digital imaging to create ...
... FORT WASHINGTON, Pa., July 28, 2011 ... announced plans for new dosing instructions lowering the maximum ... in the U.S. from 8 pills per day (4,000 ... change is designed to help encourage appropriate acetaminophen use ...
Cached Medicine Technology:Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 2Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 3McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products 2McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products 3
(Date:8/27/2014)... Aeroflow Healthcare has announced it is ... a strategic expansion of its durable medical equipment ... of new businesses through additional resources and a ... Last week, the company announced that it has ... service in the High Point/Greensboro/Winston-Salem area. This comes ...
(Date:8/27/2014)... Author and orthopedic surgeon William H. ... the thrilling adventures of sharp and witty Dr. ... gearing up for a new marketing push in the ... novellas , “Prescription: Murder” follows the adventures of Ham ... assassination attempts and thwarting criminals. In the first novella, ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 A St. ... Danis & Lowe reports that the C.R. Bard ... thousands of consolidated transvaginal mesh lawsuits, recently filed a ... #136 pertains to the pretrial discovery process, and more ... sensitive evidence. , Carey Danis & Lowe is a ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 The report ... Application (Laser designator, Laser Range Finder, LIDAR, 3D scanner, ... Gyro, Laser Doppler Vibrometer, Laser Altimeter) by Domain (Aerospace, ... 2014 - 2020” published by MarketsandMarkets, and its application ... years. The global Military Laser Systems market is expected ...
(Date:8/27/2014)... According to a new market report ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic Navigation ... and Forecast 2014 - 2020", the global surgical navigation ... 2013 and is expected to grow at a CAGR ... estimated value of USD 295.5 million in 2020. , ...
Breaking Medicine News(10 mins):Health News:Aeroflow Healthcare Seeks Strategic Acquisition Opportunities 2Health News:William H. Simon Launches New Marketing Campaign for Book 2Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3
... ... PARKER, Colo., May 1 In celebration of ... for Thought from,Parents to Children, an educational cookbook featuring ... Gand, and parents across,America. The cookbook, available at ...
... to inhale as deeply or exhale as fully as ... -- A study of women with a wide range ... the impact of asthma and also mask its severity ... in the changes in respiratory function that occur with ...
... and Promoting Future Strategies, HARRISBURG, Pa., May 1 ... today opened the PA Latino,Health Care Forum, "Sharing Progress ... the State Museum, is a follow up to the ... health disparities in,Pennsylvania. That summit was the first part ...
... PRESS CONFERENCE INVITATION, WASHINGTON, May 1 ... Economic$:, Speaker(s):, Peter I. Buerhaus, PhD, ... Interdisciplinary Health Workforce Studies, Vanderbilt,University Medical Center, Nashville, ... Policy, Partners/MGH Institute for Health Policy,Boston, MA; Beth ...
... virtual care from a team of medical experts linked ... visits than patients who do not receive this kind ... study by Rush University Medical Center. The study will ... Meeting on Friday, May 2. , Researchers studied a ...
... increasingly focused on prevention and wellness, CHICAGO, ... benefit designs and consumer engagement strategies are gaining,in ... nationwide survey of U.S.,employers, views on the value ... Group on Health (MBGH) at its 28th Annual ...
Cached Medicine News:Health News:Parents Can Educate Kids in the Kitchen With Cookbook from Chef Gale Gand and Wheat Foods Council 2Health News:Obesity May Worsen Impact of Asthma 2Health News:GACLA, Department of Health Hosts PA Latino Health Care Forum 2Health News:Will Nursing Shortage Cripple Future Health Care Plans? 2Health News:Reduced emergency room visits for elderly patients attributed to 'virtual' health care team approach 2Health News:MBGH Annual Employer Benefit Survey Reveals Growing Shift to Value-Based Benefit Design 2Health News:MBGH Annual Employer Benefit Survey Reveals Growing Shift to Value-Based Benefit Design 3Health News:MBGH Annual Employer Benefit Survey Reveals Growing Shift to Value-Based Benefit Design 4
Each handle is designed to fit a specific trephine size....
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
Permits rotation of the globe during examination. Overall length,123mm....
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
Medicine Products: